University of Vermont

Office of Technology Commercialization

Mitotherapeutix
2014

Treatment of diseases — cancer and degenerative liver disorders — by modifying or influencing metabolic pathways in cells.

UVM Inventor(s):
Ketki Madhusudan, PhD
Mercedes Rincon, PhD
Tina Thornton, PhD